- Home
- KBDC vs VALN Comparison
KBDC vs VALN Comparison
Compare KBDC & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KBDC
- VALN
- Stock Information
- Founded
- KBDC 2021
- VALN 2012
- Country
- KBDC United States
- VALN France
- Employees
- KBDC N/A
- VALN N/A
- Industry
- KBDC
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KBDC
- VALN Health Care
- Exchange
- KBDC Nasdaq
- VALN Nasdaq
- Market Cap
- KBDC 959.8M
- VALN 777.9M
- IPO Year
- KBDC N/A
- VALN 2021
- Fundamental
- Price
- KBDC $13.96
- VALN N/A
- Analyst Decision
- KBDC Buy
- VALN Strong Buy
- Analyst Count
- KBDC 4
- VALN 4
- Target Price
- KBDC $16.13
- VALN $15.75
- AVG Volume (30 Days)
- KBDC 445.1K
- VALN 77.5K
- Earning Date
- KBDC 11-10-2025
- VALN 11-06-2025
- Dividend Yield
- KBDC 13.58%
- VALN N/A
- EPS Growth
- KBDC N/A
- VALN N/A
- EPS
- KBDC N/A
- VALN N/A
- Revenue
- KBDC N/A
- VALN $230,566,060.00
- Revenue This Year
- KBDC $193.84
- VALN $15.69
- Revenue Next Year
- KBDC $7.09
- VALN $22.15
- P/E Ratio
- KBDC N/A
- VALN N/A
- Revenue Growth
- KBDC N/A
- VALN 25.47
- 52 Week Low
- KBDC $13.06
- VALN $3.62
- 52 Week High
- KBDC $17.99
- VALN $12.25
- Technical
- Relative Strength Index (RSI)
- KBDC 48.88
- VALN 50.93
- Support Level
- KBDC $13.45
- VALN $10.33
- Resistance Level
- KBDC $13.92
- VALN $11.35
- Average True Range (ATR)
- KBDC 0.27
- VALN 0.44
- MACD
- KBDC 0.09
- VALN -0.11
- Stochastic Oscillator
- KBDC 96.87
- VALN 28.66
About KBDC Kayne Anderson BDC Inc. Common Stock
Kayne Anderson BDC Inc is an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company that invests primarily in first-lien senior secured loans, with a secondary focus on unitranche and split-lien loans to middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation primarily through debt investments in middle-market companies.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.